Join
Live feed
·
INSIDERFilingvia Quantisnow
Rocket Pharmaceuticals Inc. logo

General Counsel Wilson Martin sold $6,175 worth of shares (946 units at $6.53), decreasing direct ownership by 0.63% to 149,750 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RCKT· Rocket Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RCKT (Rocket Pharmaceuticals Inc.) and more on Quantisnow.